Isavuconazole, a new investigational drug, holds promise for combatting deadly mucormycosis infections
With very few treatment options available to fight deadly mucormycosis infections, a new Los Angeles Biomedical Research Institute (LA BioMed) study holds hope for adding to the arsenal of therapies physicians have to combat an increasingly common infection afflicting people with weakened immune systems.
February 11, 2014 · by · in Nutritional News · Tags: afflicting-people, common-infection, deadly-mucormycosis, oncalldiets, research, the-arsenal, treatment-options, very-few
